Cell Dissociation Market: Industry Analysis and Forecast (2021-2027) by Technology, Product, Type, Specimen, and Region

Cell Dissociation MarketBy 2027, Cell Dissociation Market is expected to reach US$ 15.4 billion, thanks to the pharmaceutical and biotechnology industries segment. The report analyses Cell Dissociation Market dynamics and market trends.

Cell Dissociation Market Overview:

Cell dissociation, also known as trypsinization, is a procedure that uses a proteolytic enzyme to help break down protein to separate adherent cells from the cell culture medium. This breakdown is required in order for the cells to be utilized again. To boost cell viability and isolation efficiency, cell dissociation reagents can perform proteolytic and collagenolytic activities to detach cell tissues and lines from the container's glass and plastic surfaces. The tissue or cell type, as well as the age of the cells in the culture medium, decide the cell dissociation agent used. Cell Dissociation Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2026. 2020 is considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Cell Dissociation Market Dynamics:

Cell Dissociation Market size was valued at US$ 11.17 Bn. in 2020 and the total revenue is expected to grow at 4.7% through 2021 to 2027, reaching nearly US$ 15.4 Bn. To bring novel pharmaceuticals to market, key businesses in the biopharmaceutical industry are focusing on R&D in a variety of therapeutic areas. For this reason, these corporations are substantially spending on clinical trials, efficacy studies, and toxicity studies, among other research efforts. To isolate cells from primary tissues, the majority of this research utilizes tissue dissociation products. For competitors in the cell dissociation industry, emerging economies such as China, India, and Brazil are likely to offer considerable growth potential. Due to increased R&D activity in the life sciences industry in these nations, these markets are likely to grow rapidly in the future years. Pharmaceutical businesses in India, for example, are investing heavily in R&D to bring new treatments to market. Cadila Healthcare Ltd., an Indian pharmaceutical business, spent USD 113 million on research and development in 2020, up 13% from 2019. Another Indian pharmaceutical company, Biocon, spent USD 58.79 million on R&D in 2020, up 52 percent from the previous year. These investments are expected to increase the demand for cell dissociation products in the country. Animal and human cells are exploited in gene therapy studies that constitute recombination of genes and stem cell research therapies, that mostly necessitate the use of animals and humans in cell biology research. These cells are also performed to analyze medicines for in vivo toxicity and pharmacokinetics in animals and humans. Additionally, stem cell research employs human embryos for clinical applications, which frequently results in their demise. Strict restrictions have been created by ethical authorities in numerous nations across the world to supervise these operations. countries all across the world Stringent regulations for cell biology research have been implemented by authorities such as the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare Products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others. These ethical problems and constraints on cell research are severely limiting cell biology research in a variety of fields.

Recent Developments:

• In 2020, Thermo Fisher Scientific extended its strategic relationship with Symphogen (Denmark) to promote biopharmaceutical discovery and development. QIAGEN N.V. (Germany) was acquired by Thermo Fisher Scientific to extend its Specialty Diagnostics range. • Roche Diagnostics signed an ultimate merger agreement with GenMark Diagnostics in 2021 to gain access to breakthrough technologies that allow them to screen for a wide spectrum of pathogens in a single patient sample.

Cell Dissociation Market Segment Analysis:

The Enzymatic Dissociation segment is anticipated to adhere to the growth of the Cell Dissociation Market. During the forecast period, the Enzymatic dissociation products segment is expected to develop at the fastest rate. Enzymatic dissociation is the process of releasing cells from the tissue by digesting cut-up tissue fragments with enzymes. In this process, a variety of enzymes are used, and they can also be used in combination. Trypsin, collagenase, elastase, and hyaluronidase are among the most commonly employed enzymatic dissociation products, in decreasing order of frequency of use. The increasing incidence of research is attributable to the substantial percentage of this group. The Tissue Dissociation segment is estimated to grab larger market attention in the Cell Dissociation Market. In 2020, the tissue dissociation category held the greatest market share. Primary cell culture is required for numerous research and medicinal applications. Enzymatic dissociation is the process of releasing cells from the tissue by digesting cut-up tissue fragments with enzymes. In this process, a variety of enzymes are used, and they can also be used in combination. This category's substantial share can be ascribed to rising research and development spending in the pharmaceutical and biotechnology industries, which is driving segment expansion. The Pharmaceutical and Biotechnology industries segment is supplementing the growth of the Cell Dissociation Market. End-users divide the cell dissociation market into three categories: pharmaceutical and biotechnology, research and academia, and other end users. The pharmaceutical and biotechnology industries accounted for the greatest share of the cell dissociation market in 2020. Rising pharmaceutical and biotechnology investments, as well as technical improvement, are the key drivers of the industry. Furthermore, new companies are joining the market, which is expected to fuel market growth. Cell Dissociation Market

Cell Dissociation Market Regional Insights:

North America is ruling the growth of the regional cell dissociation market in the forecast period. North America's large share is likely attributable to increased research in the pharmaceutical and biotechnology industries, as well as the region's significant presence of major market players. The key drivers driving the market's growth include continued growth in the pharmaceutical and biotechnology sectors, rising cancer and other chronic illness incidences, and a strong trend of R&D investments in life sciences by industry and academia. In the United States, the federal government allocated USD 520 million to the National Cancer Institute (NCI) budget for breast cancer research, USD 800 million to clinical trials, USD 212 million to colorectal cancer research, USD 241 million to leukemia research, and another sum over USD 1 billion to other cancer types research in the economic year 2016. The objective of the report is to present a comprehensive analysis of the Cell Dissociation Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Cell Dissociation Market dynamics, structure by analyzing the market segments and projecting the Cell Dissociation Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Cell Dissociation Market make the report investor’s guide.

Cell Dissociation Market Scope: Inquire before buying

Cell Dissociation Market

Cell Dissociation Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Cell Dissociation Market Key Players

Thermo Fisher Scientific • Becton • Dickinson and Company • Roche Diagnostics (Switzerland) • Cytiva • STEMCELL Technologies (Canada) • Miltenyi Biotec (Germany) • PromoCell GmbH (Germany) • AcceGen • VitaCyte • Alstem • Biological Industries (Israel) • Gemini Bio • Innovative Cell Technologies • Central Drug House (India) • Worthington Biochemical Corporation • Capricorn Scientific (Germany) • Abeomics • Genlantis • Neuromics FAQs: 1. What is the Cell Dissociation market value in 2020? Ans: The Cell Dissociation market value in 2020 was estimated as 11.17 Billion USD. 2. Which Type is likely to dominate the Cell Dissociation market growth? Ans: The tissue dissociation segment is projected to grow at the highest CAGR during the forecast period. 3. Which Region is expected to dominate the Cell Dissociation market during the forecast period? Ans: In 2020, North America dominated the Cell Dissociation market and accounted for the largest revenue share of 51.2% owing to the presence of strong market players and increasing research activity in the biotechnology industry and pharmaceutical industry. 4. What are the factors driving the Cell Dissociation market? Ans: Key factors that are driving the CTCs market growth include growth of the market is driven mainly by the increasing prevalence of cell-based research, the increasing number of pharmaceutical and biotechnology companies. 5. Who are the key players in the Cell Dissociation market? Ans: Some key players operating in the CTCs market include Thermo Fisher Scientific , Becton, Dickinson, and Company , Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) , STEMCELL Technologies (Canada), Miltenyi Biotec (Germany).
1. Global Cell Dissociation Market: Research Methodology 2. Global Cell Dissociation Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Cell Dissociation Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Cell Dissociation Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Cell Dissociation Market Segmentation 4.1 Global Cell Dissociation Market, by Product (2020-2027) • Enzymatic Dissociation Products o Collagenase o Trypsin o Papain o Elastase o DNase o Hyaluronidase o Other Enzymes • Enzymatic Dissociation Products • Instruments 4.2 Global Cell Dissociation Market, by Tissue (2020-2027) • Connective Tissues • Epithelial Tissues • Other type tissues 4.3 Global Cell Dissociation Market, by Type (2020-2027) • Tissue dissociation • Cell detachment 4.4 Global Cell Dissociation Market, by End-user (2020-2027) • Pharmaceutical and Biotechnology companies • Research and Academics • other end users 5. North America Cell Dissociation Market (2020-2027) 5.1 North America Cell Dissociation Market, by Product (2020-2027) • Enzymatic Dissociation Products o Collagenase o Trypsin o Papain o Elastase o DNase o Hyaluronidase o Other Enzymes • Enzymatic Dissociation Products • Instruments 4.2 North America Cell Dissociation Market, by Tissue (2020-2027) • Connective Tissues • Epithelial Tissues • Other type tissues 4.3 North America Cell Dissociation Market, by Type (2020-2027) • Tissue dissociation • Cell detachment 4.4 North America Cell Dissociation Market, by End-user (2020-2027) • Pharmaceutical and Biotechnology companies • Research and Academics • other end users 6. Asia Pacific Cell Dissociation Market (2020-2027) 6.1. Asia Pacific Cell Dissociation Market, by Product (2020-2027) 6.2. Asia Pacific Cell Dissociation Market, by Tissue (2020-2027) 6.3. Asia Pacific Cell Dissociation Market, by Type (2020-2027) 6.4. Asia Pacific Cell Dissociation Market, by End-user (2020-2027) 6.5. Asia Pacific Cell Dissociation Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Cell Dissociation Market (2020-2027) 7. 1 Middle East and Africa Cell Dissociation Market, by Product (2020-2027) 7.2. Middle East and Africa Cell Dissociation Market, by Tissue (2020-2027) 7.3. Middle East and Africa Cell Dissociation Market, by Type (2020-2027) 7.4. Middle East and Africa Cell Dissociation Market, by End-user (2020-2027) 7.5. Middle East and Africa Cell Dissociation Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Cell Dissociation Market (2020-2027) 8.1. Latin America Cell Dissociation Market, by Product (2020-2027) 8.2. Latin America Cell Dissociation Market, by Tissue (2020-2027) 8.3. Latin America Cell Dissociation Market, by Type (2020-2027) 8.4. Latin America Cell Dissociation Market, by End-user (2020-2027) 8.5. Latin America Cell Dissociation Market, by Country (2020-2027) • Brazil • Argentina • Rest Of Latin America 9. European Cell Dissociation Market (2020-2027) 9.1. European Cell Dissociation Market, by Product (2020-2027) 9.2. European Cell Dissociation Market, by Tissue (2020-2027) 11.17. European Cell Dissociation Market, by Type (2020-2027) 9.4. European Cell Dissociation Market, by End-user (2020-2027) 9.5. European Cell Dissociation Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1.1. Thermo Fisher Scientific 10.1.1.1. Company Overview 10.1.1.2. Financial Overview 10.1.1.3. Geographic Footprint 10.1.1.4. Grade Portfolio 10.1.1.5. Business Strategy 10.1.1.6. Recent Developments 10.1.2. Waters Corporation 10.1.3. Thermo Fisher Scientific 10.1.4. Becton 10.1.5. Dickinson and Company 10.1.6. Roche Diagnostics 10.1.7. Cytiva 10.1.8. STEMCELL Technologies 10.1.9. Miltenyi Biotec 10.1.10. PromoCell GmbH 10.1.11. AcceGen 10.1.12. VitaCyte 10.1.13. Alstem 10.1.14. Biological Industries 10.1.15. Gemini Bio 10.1.16. Innovative Cell Technologies 10.1.17. Central Drug House 10.1.18. Worthington Biochemical Corporation 10.1.19. Capricorn Scientific 10.1.20. Abeomics 10.1.21. Genlantis 10.1.22. Neuromics

About This Report

Report ID 126091
Category Healthcare
Published Date Nov 2021
Updated Date
Contact Us